Petros Pharmaceuticals Inc
General ticker "PTPI" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.2M
Petros Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -34.5%.
Estimated limits based on current volatility of 15.9%: low 0.25$, high 0.35$
Factors to consider:
- US accounted for 80.1% of revenue in the fiscal year ended 2022-12-31
- Current price 65.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.82$, 2.63$]
- 2024-12-30 to 2025-12-30 estimated range: [1.10$, 3.22$]
Financial Metrics affecting the PTPI estimates:
- Negative: Non-GAAP EPS, $ of -11.61 <= 0.10
- Negative: Operating profit margin, % of -70.05 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -71.97 <= 2.35
Short-term PTPI quotes
Long-term PTPI plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $7.81MM | $9.38MM | $5.82MM |
Operating Expenses | $25.86MM | $29.30MM | $19.44MM |
Operating Income | $-18.05MM | $-19.92MM | $-13.62MM |
Non-Operating Income | $9.06MM | $-0.12MM | $5.45MM |
Interest Expense | $0.37MM | $0.60MM | $0.54MM |
R&D Expense | $1.79MM | $1.74MM | $2.41MM |
Income(Loss) | $-8.99MM | $-20.04MM | $-8.16MM |
Profit(Loss) | $-8.99MM | $-20.04MM | $-8.16MM |
Stockholders Equity | $35.54MM | $16.70MM | $12.48MM |
Inventory | $0.52MM | $1.82MM | $1.61MM |
Assets | $67.39MM | $32.42MM | $33.80MM |
Operating Cash Flow | $-11.86MM | $-12.80MM | $-7.63MM |
Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
Financing Cash Flow | $18.57MM | $-1.62MM | $11.54MM |
Earnings Per Share* | $-8.59 | $-13.06 | $-6.35 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.